Literature DB >> 23193025

Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cells--implications for tissue regeneration.

Chihwa Kim1, Gabriela Schneider, Ahmed Abdel-Latif, Kasia Mierzejewska, Manjula Sunkara, Sylwia Borkowska, Janina Ratajczak, Andrew J Morris, Magda Kucia, Mariusz Z Ratajczak.   

Abstract

Ceramide-1-phosphate (C1P) is a bioactive lipid that, in contrast to ceramide, is an antiapoptotic molecule released from cells that are damaged and "leaky." As reported recently, C1P promotes migration of hematopoietic cells. In this article, we tested the hypothesis that C1P released upon tissue damage may play an underappreciated role in chemoattraction of various types of stem cells and endothelial cells involved in tissue/organ regeneration. We show for the first time that C1P is upregulated in damaged tissues and chemoattracts bone marrow (BM)-derived multipotent stromal cells, endothelial progenitor cells, and very small embryonic-like stem cells. Furthermore, compared to other bioactive lipids, C1P more potently chemoattracted human umbilical vein endothelial cells and stimulated tube formation by these cells. C1P also promoted in vivo vascularization of Matrigel implants and stimulated secretion of stromal cell-derived factor-1 from BM-derived fibroblasts. Thus, our data demonstrate, for the first time, that C1P is a potent bioactive lipid released from damaged cells that potentially plays an important and novel role in recruitment of stem/progenitor cells to damaged organs and may promote their vascularization.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23193025      PMCID: PMC3582849          DOI: 10.1002/stem.1291

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  76 in total

1.  A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient.

Authors:  J Ratajczak; M Kucia; K Mierzejewska; R Liu; C H Kim; N Natarajan; V Sharma; D M Miller; J Maciejewski; M Z Ratajczak
Journal:  Leukemia       Date:  2012-02-20       Impact factor: 11.528

Review 2.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 3.  Mesenchymal stem cells as trophic mediators.

Authors:  Arnold I Caplan; James E Dennis
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

Review 4.  The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.

Authors:  M Z Ratajczak; E Zuba-Surma; M Kucia; R Reca; W Wojakowski; J Ratajczak
Journal:  Leukemia       Date:  2006-08-10       Impact factor: 11.528

5.  Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.

Authors:  Uta Kunter; Song Rong; Zivka Djuric; Peter Boor; Gerhard Müller-Newen; Donghai Yu; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2006-06-21       Impact factor: 10.121

6.  Evidence that platelet-derived microvesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD34+ hematopoietic stem/ progenitor cells--implication for the pathogenesis of immune thrombocytopenias.

Authors:  Marcin Majka; Jacek Kijowski; Ewa Lesko; Jolanta Goźdizk; Barbara Zupanska; Mariusz Z Ratajczak
Journal:  Folia Histochem Cytobiol       Date:  2007       Impact factor: 1.698

7.  Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

Authors:  Dietlind Zohlnhöfer; Ilka Ott; Julinda Mehilli; Kathrin Schömig; Fabian Michalk; Tareq Ibrahim; Günther Meisetschläger; Jasper von Wedel; Hildegard Bollwein; Melchior Seyfarth; Josef Dirschinger; Claus Schmitt; Markus Schwaiger; Adnan Kastrati; Albert Schömig
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

8.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.

Authors:  H Castro-Malaspina; R E Gay; G Resnick; N Kapoor; P Meyers; D Chiarieri; S McKenzie; H E Broxmeyer; M A Moore
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

9.  G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.

Authors:  Evangelia Yannaki; Evangelia Athanasiou; Angeliki Xagorari; Varnavas Constantinou; Ioannis Batsis; Panagiotis Kaloyannidis; Evangelia Proya; Achilles Anagnostopoulos; Athanasios Fassas
Journal:  Exp Hematol       Date:  2005-01       Impact factor: 3.084

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  35 in total

1.  An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production.

Authors:  Young-Il Kim; Kyungho Park; Jong Youl Kim; Ho Seong Seo; Kyong-Oh Shin; Yong-Moon Lee; Walter M Holleran; Peter M Elias; Yoshikazu Uchida
Journal:  Mol Cell Biol       Date:  2014-10-13       Impact factor: 4.272

2.  Regulation of the amount of ceramide-1-phosphate synthesized in differentiated human podocytes.

Authors:  Shamroop Kumar Mallela; Alla Mitrofanova; Sandra Merscher; Alessia Fornoni
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-09-02       Impact factor: 4.698

Review 3.  Ceramide signaling in mammalian epidermis.

Authors:  Yoshikazu Uchida
Journal:  Biochim Biophys Acta       Date:  2013-09-19

4.  High spatial resolution imaging mass spectrometry of human optic nerve lipids and proteins.

Authors:  David M G Anderson; Jeffrey M Spraggins; Kristie L Rose; Kevin L Schey
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-17       Impact factor: 3.109

5.  Analysis of Molecular Species Profiles of Ceramide-1-phosphate and Sphingomyelin Using MALDI-TOF Mass Spectrometry.

Authors:  Ryouhei Yamashita; Yumika Tabata; Erina Iga; Michiyasu Nakao; Shigeki Sano; Kentaro Kogure; Akira Tokumura; Tamotsu Tanaka
Journal:  Lipids       Date:  2015-12-22       Impact factor: 1.880

6.  The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.

Authors:  Hyunsook Kang; Kang-Hyun Kim; Jisun Lim; You-Sun Kim; Jinbeom Heo; Jongjin Choi; Jaeho Jeong; YongHwan Kim; Seong Who Kim; Yeon-Mok Oh; Myung-Soo Choo; Jaekyoung Son; Su Jung Kim; Hyun Ju Yoo; Wonil Oh; Soo Jin Choi; Sei Won Lee; Dong-Myung Shin
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

Review 7.  Stem cells and their potential clinical applications in psychiatric disorders.

Authors:  Mariusz Z Ratajczak; Andrzej K Ciechanowicz; Jolanta Kucharska-Mazur; Jerzy Samochowiec
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-04-20       Impact factor: 5.067

8.  Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.

Authors:  Gabriela Schneider; Ewa Bryndza; Ahmed Abdel-Latif; Janina Ratajczak; Magdalena Maj; Maciej Tarnowski; Yuri M Klyachkin; Peter Houghton; Andrew J Morris; Axel Vater; Sven Klussmann; Magdalena Kucia; Mariusz Z Ratajczak
Journal:  Mol Cancer Res       Date:  2013-04-24       Impact factor: 5.852

9.  Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction.

Authors:  Anush V Karapetyan; Yuri M Klyachkin; Samy Selim; Manjula Sunkara; Khaled M Ziada; Donald A Cohen; Ewa K Zuba-Surma; Janina Ratajczak; Susan S Smyth; Mariusz Z Ratajczak; Andrew J Morris; Ahmed Abdel-Latif
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272

10.  Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy.

Authors:  Gabriela Schneider; Zachariah Payne Sellers; Ahmed Abdel-Latif; Andrew J Morris; Mariusz Z Ratajczak
Journal:  Mol Cancer Res       Date:  2014-07-17       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.